|By Marketwired .||
|April 23, 2013 08:15 AM EDT||
DENVER, CO -- (Marketwired) -- 04/23/13 -- MusclePharm Corporation (OTCQB: MSLP), a nutritional supplement company focused on active lifestyles, is proud to announce it has signed an endorsement deal with the reigning UFC Lightweight Champion and 2012 UFC Fighter of the Year, Benson "Smooth" Henderson.
As part of the relationship, Henderson will represent MusclePharm in a series of advertisements, media appearances, and social media outlets. Additionally, MusclePharm's unmistakable, bright lime green logo will be displayed on both Henderson's shorts and fight banners.
The 29-year-old Henderson defended his UFC Lightweight title in the headliner main event this past Saturday on the nationally televised "UFC on FOX 7," when he faced off against top-ranked challenger, Gilbert Melendez. Henderson has become one of the UFC's top fighters having now won all four of his Lightweight title fights.
Commenting on the announcement, Henderson stated, "To compete at the championship level in the UFC, a fighter must endure endless hours of training and push himself to achieve or exceed his workout goals. MusclePharm's line of sports nutrition products provide me the fuel I need to be successful. I am excited to become part of MusclePharm's team of professional athletes."
Commenting on the announcement, MusclePharm Founder & CEO Brad Pyatt stated, "MusclePharm is very proud of its status as the official nutritional supplement provider of the UFC. Henderson is one of UFC's most popular and charismatic title holders. His chiseled body and powerful ruggedness fit perfectly with the MusclePharm brand."
This is the fourth professional athlete endorsement deal MusclePharm has recently announced. Over the recent weeks, the Company has announced endorsement deals with the NFL San Francisco 49ers Super Bowl quarterback Colin Kaepernick, Denver Broncos star wide receiver Eric Decker and international rugby superstar Quade Cooper.
ABOUT MUSCLEPHARM CORPORATION
MusclePharm is a healthy lifestyle company that develops and manufactures nutritional supplements which address active lifestyles, including muscle building, weight loss and maintaining general fitness through a daily nutritional supplement regimen. The products are formulated through a six-stage research process using the expertise of leading nutritional scientists. MusclePharm's products are sold to consumers in more than 90 countries and available in over 10,500 U.S. retail outlets, including Dick's Sporting Goods, GNC, Vitamin Shoppe and Vitamin World. MusclePharm products also are sold through more than 100 online channels globally, including bodybuilding.com, amazon.com and vitacost.com. MusclePharm also owns FitMiss, a branded line of fitness supplements which is designed, dosed and formulated specifically for women with active lifestyles. For more information, please visit http://musclepharm.com/.
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as "expects", "anticipates", "intends", "estimates", "plans", "potential", "possible", "probable", "believes", "seeks", "may", "will", "should", "could" or the negative of such terms or other similar expressions. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the Company's business. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's Annual Report on Form 10-K/A for the fiscal year ended December 31, 2011, the Company's Quarter Reports on Form 10-Q and other filings submitted by the Company to the SEC, copies of which may be obtained from the SEC's website at www.sec.gov. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and the Company undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof.
MusclePharm Company Contact:
John H. Bluher
MusclePharm Investor Contact:
The Del Mar Consulting Group, Inc.
Robert B. Prag
Email: Email Contact
Alex Partners, LLC
Email: Email Contact